413 related articles for article (PubMed ID: 20424465)
1. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
[TBL] [Abstract][Full Text] [Related]
2. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease.
Dias AE; Barbosa ER; Coracini K; Maia F; Marcolin MA; Fregni F
Acta Neurol Scand; 2006 Feb; 113(2):92-9. PubMed ID: 16411969
[TBL] [Abstract][Full Text] [Related]
3. [Parkinsonian dysarthria].
Gentil M; Pollak P; Perret J
Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
[TBL] [Abstract][Full Text] [Related]
4. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.
Eliasova I; Mekyska J; Kostalova M; Marecek R; Smekal Z; Rektorova I
J Neural Transm (Vienna); 2013 Apr; 120(4):597-605. PubMed ID: 23254927
[TBL] [Abstract][Full Text] [Related]
5. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
[TBL] [Abstract][Full Text] [Related]
6. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
[TBL] [Abstract][Full Text] [Related]
7. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease.
Hamada M; Ugawa Y; Tsuji S;
Mov Disord; 2008 Aug; 23(11):1524-31. PubMed ID: 18548577
[TBL] [Abstract][Full Text] [Related]
8. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
9. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
Skodda S; Rinsche H; Schlegel U
Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
[TBL] [Abstract][Full Text] [Related]
10. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
Tjaden K; Wilding GE
J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
[TBL] [Abstract][Full Text] [Related]
11. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility.
Rousseaux M; Krystkowiak P; Kozlowski O; Ozsancak C; Blond S; Destée A
J Neurol; 2004 Mar; 251(3):327-34. PubMed ID: 15015014
[TBL] [Abstract][Full Text] [Related]
12. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
Pinto S; Ghio A; Teston B; Viallet F
Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
[TBL] [Abstract][Full Text] [Related]
13. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease.
Okabe S; Ugawa Y; Kanazawa I;
Mov Disord; 2003 Apr; 18(4):382-8. PubMed ID: 12671943
[TBL] [Abstract][Full Text] [Related]
14. Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson's disease.
Filipović SR; Rothwell JC; Bhatia K
J Neurol Sci; 2010 Apr; 291(1-2):1-4. PubMed ID: 20153482
[TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease.
del Olmo MF; Bello O; Cudeiro J
Clin Neurophysiol; 2007 Jan; 118(1):131-9. PubMed ID: 17097342
[TBL] [Abstract][Full Text] [Related]
16. Effect of repetitive transcranial magnetic stimulation over the hand motor cortical area on central pain after spinal cord injury.
Kang BS; Shin HI; Bang MS
Arch Phys Med Rehabil; 2009 Oct; 90(10):1766-71. PubMed ID: 19801069
[TBL] [Abstract][Full Text] [Related]
17. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
[TBL] [Abstract][Full Text] [Related]
18. Vocal acoustic characteristics of patients with Parkinson's disease.
Tanaka Y; Nishio M; Niimi S
Folia Phoniatr Logop; 2011; 63(5):223-30. PubMed ID: 21212679
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled study of rTMS for the treatment of Parkinson's disease.
Lomarev MP; Kanchana S; Bara-Jimenez W; Iyer M; Wassermann EM; Hallett M
Mov Disord; 2006 Mar; 21(3):325-31. PubMed ID: 16211618
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke.
Ameli M; Grefkes C; Kemper F; Riegg FP; Rehme AK; Karbe H; Fink GR; Nowak DA
Ann Neurol; 2009 Sep; 66(3):298-309. PubMed ID: 19798637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
